Evidence map›Paper›PMID 41553041›Full record

Observational studyJournal of human nutrition and dietetics : the official journal of the British Dietetic Association2026

Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study.

Lisa C Murnane, Adrienne K Forsyth, Jim Koukounaras, Kalai Shaw, Eldho Paul, Wendy A Brown, Audrey C Tierney, Paul R Burton

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisa C MurnaneSchool of Allied Health, Human Services and Sport, La Trobe University, Melbourne, Australia.ORCID https://orcid.org/0000-0002-6209-9929
Adrienne K ForsythSchool of Allied Health, Human Services and Sport, La Trobe University, Melbourne, Australia.ORCID https://orcid.org/0000-0002-1692-2638
Jim KoukounarasDepartment of Radiology, Alfred Health, Melbourne, Australia.
Kalai ShawDepartment of Surgery, Monash University, Melbourne, Australia.
Eldho PaulSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Wendy A BrownDepartment of Surgery, Monash University, Melbourne, Australia.
Audrey C TierneySchool of Allied Health, Human Services and Sport, La Trobe University, Melbourne, Australia.
Paul R BurtonDepartment of Surgery, Monash University, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLow skeletal muscle is prevalent and associated with poorer outcomes after oesophagogastric (OG) cancer surgery. However, sarcopenia, including strength and function, is less commonly assessed. Therefore, we aimed to describe the prevalence of sarcopenia and changes in diagnostic criteria within 1 year of OG cancer surgery.

methodsThis prospective observational study included OG cancer surgery patients from 2018 to 2021. Body composition was assessed using computed tomography (CT) and bioimpedance spectroscopy (BIS). Low CT-defined skeletal muscle index (SMI) and myosteatosis were defined using published thresholds. Low fat-free mass index (FFMI) cut points were < 17 kg/m

resultsForty-eight patients, predominantly male (63%) with a mean (SD) age of 64 (10.1) years, were included preoperatively, and 25 patients at 1 year. Low SMI (50%) and myosteatosis (50%) were prevalent preoperatively. Fewer patients had low FFMI (6%), low HGS (17%), and low walk speed (6%). The prevalence of Sarcopenia-CT was 15% preoperatively and 12% at 1-year (p = 0.32), and sarcopenia-BIS was 2% preoperatively and 3% at 1-year (p = 0.60).

conclusionsDespite a high prevalence of low SMI and myosteatosis, sarcopenia was less common. Low muscle mass, with adequate strength and function, is a prominent feature. Given the negative outcomes of low SMI, muscle assessment remains a valuable and clinically meaningful measure.

Indexed as

Esophageal NeoplasmsPostoperative ComplicationsSarcopeniaStomach NeoplasmsAgedBody CompositionFemaleHand StrengthHumansLongitudinal StudiesMaleMiddle AgedMuscle, SkeletalPrevalenceProspective StudiesTomography, X-Ray Computedcancerfunctionmuscle masssarcopeniastrengthsurgery

Identifiers

PMID41553041
PMCPMC12814763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.